Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis

NCT: NCT06311292 · COMPLETED

NCT IDNCT06311292
StatusCOMPLETED
Start Date2024-05-29
Completion2025-03-19

Brief Summary

This is a small pilot study with the goal of identifying a superior sputum collection method in Cystic Fibrosis patients unable to produce a sputum. Participants will use the Volara System during clinic visit in an attempt to produce sputum.

Frequently Asked Questions

What is Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis?

Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis is a clinical trial registered under NCT06311292. Current status: COMPLETED.

What is the status of NCT06311292?

The current status of NCT06311292 (Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis) is: COMPLETED.

When did Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis start?

Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis started on 2024-05-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.